Additional Information
Market: LSE
Sector: Electronic & Electrical Equipment
EPIC: SXS
Latest Price: 1,576.00p  (-2.72% Descending)
52-week High: 1,708.00p
52-week Low: 1,029.00p
Market Cap: 1,834.05M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Spectris plc
www.spectris.com

Spectris plc is engaged in the development and marketing of precision instrumentation and controls. It operates in four segments.

Pdf

Spectris sees better-than-expected FY2010 as demand improves in H1

16th Jul 2010, 10:40 am Spectris sees better-than-expected FY2010 as demand improves in H1

FTSE250 instrument and controls company Spectris (LON:SXS) told investors that further to the last trading statement in May, it is continuing to see an improvement in demand over the prior year, with signs of recovery throughout most regions and end markets.

The company now expects to report 8% sales growth - on a organic like-for-like basis - for the first six months of the 2010 financial year.

“The first six months of 2010 have been encouraging ... we expect to continue to make good progress and deliver results for the full year ahead of the board's earlier expectations,” Spectris said.

Investors on the London Stock Exchange embraced the upbeat statement, with shares advancing 7.7% to trade at 898p midmorning. Earlier today the stock reached an intraday high of 949p.

On a reported basis the company expects full-year revenues to increase by approximately 9%, and adjusted operating profit is expected to be in the region of £50m (FY09: £20m), based on adjusted operating margins of approximately 12.3%.

“All four segments will show like-for-like revenue growth in the first half. We continue to see a faster recovery in the In-line Instrumentation and Industrial Controls segments than in Test & Measurement and Materials Analysis.”

“On a regional basis, Asia Pacific continues to lead the growth with sales expected to be up by 23% on a constant currency basis. In North America, sales will be up by 14%, while European sales will see a 3% decline.”

The company noted that its cash conversion was very good, and its financial position remains strong.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.